Novel Machine Learning Imaging Biomarkers: Adding Value to Clinical Trials for Novel Therapeutics

Time: 10:45 am
day: Day Two


Advanced image analytics of Optical Coherence Tomography enable:

  • Meaningful stratification of trial participants and targeted trial design
  • Improved efficiency of screening through automated processing of high-volume imaging databases for relevant biomarkers
  • Prediction modelling for response to anti-VEGF and other emerging therapeutics